Mochida Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3922800002
JPY
3,240.00
30 (0.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
31,719.00
29,464.00
32,502.00
28,354.00
26,631.00
24,428.00
29,635.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
31,719.00
29,464.00
32,502.00
28,354.00
26,631.00
24,428.00
29,635.00
Raw Material Cost
17,031.00
15,062.00
17,495.00
15,128.00
13,005.00
12,089.00
13,471.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
43.00
42.00
29.00
1.00
0.00
1.00
1.00
Selling and Distribution Expenses
8,653.00
8,608.00
8,766.00
8,317.00
8,265.00
8,529.00
8,740.00
Other Expenses
242.70
313.10
365.30
251.30
278.80
292.60
397.20
Total Expenditure (Excl Depreciation)
28,154.00
26,843.00
29,943.00
25,959.00
24,058.00
23,545.00
26,184.00
Operating Profit (PBDIT) excl Other Income
3565
2621
2559
2395
2573
883
3451
Other Income
1,343.00
268.00
642.00
3.00
211.00
-459.00
110.00
Operating Profit (PBDIT)
5,638.00
3,678.00
3,970.00
3,123.00
3,480.00
1,197.00
4,310.00
Interest
43.00
42.00
29.00
1.00
0.00
1.00
1.00
Exceptional Items
0.00
-24.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
14,688.00
14,402.00
15,007.00
13,226.00
13,626.00
12,339.00
16,164.00
Depreciation
730.00
789.00
769.00
725.00
696.00
773.00
749.00
Profit Before Tax
4,866.00
2,824.00
3,167.00
2,398.00
2,782.00
423.00
3,561.00
Tax
1,687.00
1,263.00
681.00
435.00
888.00
344.00
781.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,178.00
1,561.00
2,486.00
1,962.00
1,894.00
80.00
2,780.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,178.00
1,561.00
2,486.00
1,962.00
1,894.00
80.00
2,780.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,178.00
1,561.00
2,486.00
1,962.00
1,894.00
80.00
2,780.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,40,293.00
1,40,326.00
1,37,431.00
1,35,206.00
1,31,152.00
1,30,694.00
1,30,316.00
Earnings per share (EPS)
89.75
44.03
70.13
55.35
53.43
2.26
78.42
Diluted Earnings per share
89.75
44.03
70.13
55.35
53.43
2.26
78.42
Operating Profit Margin (Excl OI)
11.24%
8.9%
7.87%
8.45%
9.66%
3.61%
11.65%
Gross Profit Margin
17.64%
12.26%
12.11%
11.01%
13.06%
4.9%
14.54%
PAT Margin
10.02%
5.3%
7.65%
6.92%
7.11%
0.33%
9.38%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 19.11% vs 4.82% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 67.79% vs 21.88% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 31.39% vs 12.92% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Mochida Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
31,719.00
71,380.00
-39,661.00
-55.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
31,719.00
71,380.00
-39,661.00
-55.56%
Raw Material Cost
17,031.00
45,281.00
-28,250.00
-62.39%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
43.00
628.00
-585.00
-93.15%
Selling and Distribution Expenses
8,653.00
19,579.00
-10,926.00
-55.80%
Other Expenses
242.70
-62.80
305.50
486.46%
Total Expenditure (Excl Depreciation)
28,154.00
64,860.00
-36,706.00
-56.59%
Operating Profit (PBDIT) excl Other Income
3,565.00
6,520.00
-2,955.00
-45.32%
Other Income
1,343.00
825.00
518.00
62.79%
Operating Profit (PBDIT)
5,638.00
12,407.00
-6,769.00
-54.56%
Interest
43.00
628.00
-585.00
-93.15%
Exceptional Items
0.00
1,227.00
-1,227.00
-100.00%
Gross Profit (PBDT)
14,688.00
26,099.00
-11,411.00
-43.72%
Depreciation
730.00
5,062.00
-4,332.00
-85.58%
Profit Before Tax
4,866.00
7,943.00
-3,077.00
-38.74%
Tax
1,687.00
2,412.00
-725.00
-30.06%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,178.00
5,531.00
-2,353.00
-42.54%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,178.00
5,531.00
-2,353.00
-42.54%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,178.00
5,531.00
-2,353.00
-42.54%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,40,293.00
1,82,476.00
-42,183.00
-23.12%
Earnings per share (EPS)
89.75
112.36
-22.61
-20.12%
Diluted Earnings per share
89.75
112.36
-22.61
-20.12%
Operating Profit Margin (Excl OI)
11.24%
9.13%
0.00
2.11%
Gross Profit Margin
17.64%
18.22%
0.00
-0.58%
PAT Margin
10.02%
7.75%
0.00
2.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,171.90 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 7.65% vs -9.35% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 19.11% vs 4.82% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 317.80 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 103.59% vs -37.21% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 67.79% vs 21.88% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 429.50 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 25.95% vs 2.46% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 31.39% vs 12.92% in Jun 2025

Quarterly - Interest
Interest 4.30 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 2.38% vs 44.83% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.24%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025